pH-responsive mesoporous silica nanoparticles employed in controlled drug delivery systems for cancer treatment

In the fight against cancer, controlled drug delivery systems have emerged to enhance the therapeutic efficacy and safety of anti-cancer drugs. Among these systems, mesoporous silica nanoparticles (MSNs) with a functional surface possess obvious advantages and were thus rapidly developed for cancer treatment. Many stimuli-responsive materials, such as nanoparticles, polymers, and inorganic materials, have been applied as caps and gatekeepers to control drug release from MSNs. This review presents an overview of the recent progress in the production of pH-responsive MSNs based on the pH gradient between normal tissues and the tumor microenvironment. Four main categories of gatekeepers can respond to acidic conditions. These categories will be described in detail.

[1]  Patrick Couvreur,et al.  Stimuli-responsive nanocarriers for drug delivery. , 2013, Nature materials.

[2]  Véronique Préat,et al.  To exploit the tumor microenvironment: Passive and active tumor targeting of nanocarriers for anti-cancer drug delivery. , 2010, Journal of controlled release : official journal of the Controlled Release Society.

[3]  Linlin Li,et al.  Mesoporous Silica Nanoparticles: Synthesis, Biocompatibility and Drug Delivery , 2012, Advanced materials.

[4]  X. Mo,et al.  Polyelectrolyte multilayer functionalized mesoporous silica nanoparticles for pH-responsive drug delivery: layer thickness-dependent release profiles and biocompatibility. , 2013, Journal of materials chemistry. B.

[5]  C. Kojima.  Design of stimuli-responsive dendrimers , 2010, Expert opinion on drug delivery.

[6]  T. Chen,et al.  pH-responsive nanovalves based on hollow mesoporous silica spheres for controlled release of corrosion inhibitor , 2012, Nanotechnology.

[7]  Marilena Loizidou,et al.  Liposomes and nanoparticles: nanosized vehicles for drug delivery in cancer. , 2009, Trends in pharmacological sciences.

[8]  Li Yuan,et al.  Preparation of pH-Responsive Mesoporous Silica Nanoparticles and Their Application in Controlled Drug Delivery , 2011 .

[9]  H. Maeda.  The enhanced permeability and retention (EPR) effect in tumor vasculature: the key role of tumor-selective macromolecular drug targeting. , 2001, Advances in enzyme regulation.

[10]  R. Venkatasubramanian,et al.  A stimulus-responsive magnetic nanoparticle drug carrier: magnetite encapsulated by chitosan-grafted-copolymer. , 2008, Acta biomaterialia.

[11]  H. Dai,et al.  PEG branched polymer for functionalization of nanomaterials with ultralong blood circulation. , 2009, Journal of the American Chemical Society.

[12]  S. Liao,et al.  A biocompatible drug delivery nanovalve system on the surface of mesoporous nanoparticles , 2012 .

[13]  S. Jeong,et al.  pH-Tunable calcium phosphate covered mesoporous silica nanocontainers for intracellular controlled release of guest drugs. , 2011, Angewandte Chemie.

[14]  Lei Xing,et al.  Coordination Polymer Coated Mesoporous Silica Nanoparticles for pH‐Responsive Drug Release , 2012, Advanced materials.

[15]  D. Lu,et al.  pH-sensitive poly(glutamic acid) grafted mesoporous silica nanoparticles for drug delivery. , 2013, International journal of pharmaceutics.

[16]  Yingwei Yang.  Towards biocompatible nanovalves based on mesoporous silica nanoparticles , 2011 .

[17]  J. F. Stoddart,et al.  pH clock-operated mechanized nanoparticles. , 2009, Journal of the American Chemical Society.

[18]  Jia Guo,et al.  pH-responsive composite microspheres based on magnetic mesoporous silica nanoparticle for drug delivery. , 2013, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[19]  L. J. Mueller,et al.  pH-responsive nanogated ensemble based on gold-capped mesoporous silica through an acid-labile acetal linker. , 2010, Journal of the American Chemical Society.

[20]  T. Andresen,et al.  Advanced strategies in liposomal cancer therapy: problems and prospects of active and tumor specific drug release. , 2005, Progress in lipid research.

[21]  Vladimir P. Torchilin,et al.  Liposomes as ‘smart’ pharmaceutical nanocarriers , 2010 .

[22]  Xiaoxi Hu,et al.  Chitosan-capped mesoporous silica nanoparticles as pH-responsive nanocarriers for controlled drug release. , 2014, Chemistry, an Asian journal.

[23]  C. Mou,et al.  Intracellular pH-responsive mesoporous silica nanoparticles for the controlled release of anticancer chemotherapeutics. , 2010, Angewandte Chemie.

[24]  Robert Langer,et al.  Impact of nanotechnology on drug delivery. , 2009, ACS nano.

[25]  K. Ulbrich,et al.  Core-crosslinked polymeric micelles with controlled release of covalently entrapped doxorubicin. , 2010, Biomaterials.

[26]  Chun-Yan Hong,et al.  Fabrication of PDEAEMA-Coated Mesoporous Silica Nanoparticles and pH-Responsive Controlled Release , 2010 .

[27]  Vladimir Torchilin,et al.  Multifunctional and stimuli-sensitive pharmaceutical nanocarriers. , 2009, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[28]  B. Nanjwade,et al.  Dendrimers: emerging polymers for drug-delivery systems. , 2009, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[29]  Mark E. Davis,et al.  Nanoparticle therapeutics: an emerging treatment modality for cancer , 2008, Nature Reviews Drug Discovery.

[30]  Changren Zhou,et al.  Polysaccharides-based nanoparticles as drug delivery systems. , 2008, Advanced drug delivery reviews.

[31]  J. F. Stoddart,et al.  Autonomous in vitro anticancer drug release from mesoporous silica nanoparticles by pH-sensitive nanovalves. , 2010, Journal of the American Chemical Society.

[32]  P. Couvreur,et al.  Doxorubicin-loaded nanospheres bypass tumor cell multidrug resistance. , 1992, Biochemical pharmacology.

[33]  G. Lu,et al.  A pH-responsive drug delivery system based on chitosan coated mesoporous silica nanoparticles , 2012 .

[34]  Pingyun Feng,et al.  Responsive polymer-coated mesoporous silica as a pH-sensitive nanocarrier for controlled release. , 2011, Langmuir : the ACS journal of surfaces and colloids.

[35]  Jia Guo,et al.  Thermo and pH dual responsive, polymer shell coated, magnetic mesoporous silica nanoparticles for controlled drug release , 2011 .

[36]  Aifei Wang,et al.  pH-Triggered controlled drug release from mesoporous silica nanoparticles via intracelluar dissolution of ZnO nanolids. , 2011, Journal of the American Chemical Society.

[37]  Jinming Gao,et al.  Multifunctional Micellar Nanomedicine for Cancer Therapy , 2009, Experimental biology and medicine.

[38]  Jun Lin,et al.  Functionalized mesoporous silica materials for controlled drug delivery. , 2012, Chemical Society reviews.

[39]  Umer Rashid,et al.  Nanomaterials in combating cancer: therapeutic applications and developments. , 2014, Nanomedicine : nanotechnology, biology, and medicine.

[40]  J. Fraser Stoddart,et al.  Mesoporous Silica Nanoparticles in Biomedical Applications , 2012 .

[41]  S. Nie,et al.  Therapeutic Nanoparticles for Drug Delivery in Cancer Types of Nanoparticles Used as Drug Delivery Systems , 2022 .

[42]  S. Feng,et al.  A novel controlled release formulation for the anticancer drug paclitaxel (Taxol): PLGA nanoparticles containing vitamin E TPGS. , 2003, Journal of controlled release : official journal of the Controlled Release Society.

[43]  Jia Guo,et al.  Facile synthesis of pH sensitive polymer-coated mesoporous silica nanoparticles and their application in drug delivery. , 2011, International journal of pharmaceutics.

[44]  P. Couvreur,et al.  Nanoparticles in cancer therapy and diagnosis. , 2002, Advanced drug delivery reviews.

[45]  Xiao-ling Fang,et al.  In vivo distribution and antitumor activity of doxorubicin-loaded N-isopropylacrylamide-co-methacrylic acid coated mesoporous silica nanoparticles and safety evaluation. , 2013, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[46]  Lin Zhu,et al.  Stimulus-responsive nanopreparations for tumor targeting. , 2013, Integrative biology : quantitative biosciences from nano to macro.

[47]  Larry A. Sklar,et al.  Control of Molecular Transport Through Stimuli‐Responsive Ordered Mesoporous Materials , 2003 .

[48]  Guonan Chen,et al.  A pH-responsive controlled release system using layered double hydroxide (LDH)-capped mesoporous silica nanoparticles. , 2013, Journal of materials chemistry. B.

[49]  Linqi Shi,et al.  A multifunctional nanocarrier based on nanogated mesoporous silica for enhanced tumor-specific uptake and intracellular delivery. , 2012, Macromolecular bioscience.